Appikon för AgingResearch.News: Longevity

AgingResearch.News: Longevity

Inget anspråk gjort

The fastest way to know what really works in longevity

Av PAPERFOOT AI PTE. LTD. · Socialt
Debuts-poäng 76NyGe det första betyget

Därför förväntar vi oss mycket av den: Clear, well-documented value for longevity researchers, with evidence-focused descriptions and useful follow and alert features.

AgingResearch.News: Longevity skärmbild 1AgingResearch.News: Longevity skärmbild 2AgingResearch.News: Longevity skärmbild 3AgingResearch.News: Longevity skärmbild 4AgingResearch.News: Longevity skärmbild 5

Liknande appar i kategorin Socialt

Se de bästa

Kort sagt

AgingResearch.News: Longevity scans ageing research papers from sources such as PubMed and bioRxiv, summarises their findings in plain English with citations, and ranks them on evidence. It suits people following longevity science, including researchers, who can follow topics and export references to Zotero, EndNote or Mendeley. It stands out for showing, at a glance, what was studied, in which subjects, and the catch.

Sammanfattning från Debuts, baserad på appsidan i App Store.

Fler appar i kategorin Socialt

Veckans bästa nya appar i kategorin Socialt

Om appen

The fastest way to know what really works in longevity.

AgingResearch.News scans the world’s ageing research in real time: 1,800+ papers an hour from PubMed, bioRxiv, medRxiv, arXiv, Europe PMC and journals worldwide. It reads every one, weighs the evidence and tells you what it found in plain English, with every claim cited. Over 690,000 papers so far.

NEVER MISS A BREAKTHROUGH The papers that matter, ranked on evidence, never on fame. What was studied, in whom, what changed, and the catch, at a glance. Mouse, cell or human: you see it instantly.

FOLLOW WHAT YOU CARE ABOUT Follow a drug, gene, pathway, disease, lab or author, and get an alert the moment a new paper on it lands. Rapamycin, senolytics, NAD+, metformin, GLP-1s, epigenetic clocks, reprogramming: thousands of subjects, each with an evidence profile from cells and mice to human trials.

ASK THE LITERATURE Ask anything about ageing research and get an answer in seconds, drawn from the papers, with the sources to check.

SEE THE FIGURES Every paper’s own figures, a tap away. Save papers to read later, on your phone and on the web.

PLUS For you: your field, ranked for your own research, with a match score on every paper. 20 questions a day to Ask, 5 interests and 25 follows, each with its own alerts, and export to Zotero, EndNote or Mendeley. One subscription works in the app and on agingresearch.news.

PRO Everything in Plus, with 500 questions a day to Ask, 25 interests, unlimited follows and 10 email digests. On agingresearch.news: company profiles, asset records, dashboards, watchlists and the catalyst calendar, 25 Ultradeep reviews a day, due-diligence packs, and the API and MCP server.

Plus and Pro renew automatically unless cancelled at least 24 hours before the period ends. Manage or cancel them in your Apple Account settings.

Terms of Use (EULA): https://www.apple.com/legal/internet-services/itunes/dev/stdeula/ Terms: https://agingresearch.news/terms Privacy: https://agingresearch.news/privacy

Frågor om AgingResearch.News: Longevity

Vad är AgingResearch.News: Longevity?
AgingResearch.News: Longevity scans ageing research papers from sources such as PubMed and bioRxiv, summarises their findings in plain English with citations, and ranks them on evidence. It suits people following longevity science, including researchers, who can follow topics and export references to Zotero, EndNote or Mendeley. It stands out for showing, at a glance, what was studied, in which subjects, and the catch.
Är AgingResearch.News: Longevity gratis?
Ja. AgingResearch.News: Longevity är gratis att ladda ner.
Vilka enheter fungerar AgingResearch.News: Longevity på?
AgingResearch.News: Longevity fungerar på iPhone, iPad.
Vilka språk finns AgingResearch.News: Longevity på?
AgingResearch.News: Longevity finns på 11 språk, bland annat tyska, engelska, spanska, franska, italienska, japanska.
Vem utvecklar AgingResearch.News: Longevity?
AgingResearch.News: Longevity är utvecklad av PAPERFOOT AI PTE. LTD.. Åldersgränsen i App Store är 12+.
Vilka alternativ finns till AgingResearch.News: Longevity?
Liknande appar på Debuts: Chaluu: Accessible Messaging, Vigia Brasília, Fanfold: News as Magazines.

Så betygsätter folk den

Logga in för att betygsätta appen. Det ärliga betyget räknas.

Inga betyg ännu. Har du provat appen? Ge det första betyget.

Signaler för upptäckt

Så upptäcker AI och människor AgingResearch.News: Longevity på Debuts
AI-redoDelvis
78 % beskrivet för att AI ska kunna matcha
Går att hitta nuLiveStrukturerad data på den här sidan och Debuts API

Berätta vad du gillar. Vi mejlar bara när något nytt matchar, och utvecklare lägger ofta till ett erbjudande för testare.

Vilken sorts appar
På min
Visa bara
Hur ofta
Vi skickar en länk för att bekräfta. Inget kommer innan du har klickat på den.